Acurx Pharmaceuticals Inc
ACXP
NSC
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
4.78
USD
0.26
(5.75%)
Optionable: No Market Cap: 46 M 90-day average vol: 19,856
Previous close: 4.52 Open: 4.61 Bid: 4.82 Ask: 4.82
52 week range
2.33 5.92
Last updated: Thursday 11th August 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Chart
News
Acurx Announces Publication of Positive Phase 2a Clinical Trial Results of Ibezapolstat for CDI in Clinical Infectious Diseases
Yahoo Finance 2/7/2022
Acurx Announces First Patient Enrolled in Phase 2b Clinical Trial of its Lead Antibiotic for Treatment of Clostridioides difficile Infection (CDI)
Yahoo Finance 12/6/2021
Acurx Pharmaceuticals, Inc. (ACXP) CEO David Luci on Q3 2021 Earnings Call Transcript
Seeking Alpha 11/15/2021
Acurx Pharmaceuticals reports Q3 results
Seeking Alpha 11/15/2021
Acurx Pharmaceuticals, Inc. Reports Third Quarter 2021 Results and Provides Business Update
Yahoo Finance 11/12/2021
Acurx Announces New Microbiome Data from Its Phase 2a Clinical Trial of Ibezapolstat for CDI at the 9th International C. diff. Conference
Yahoo Finance 11/8/2021
Acurx Pharmaceuticals to Discuss 2021 Third Quarter Financial Results on November 15, 2021 Conference Call and Provide Business Update
Yahoo Finance 10/27/2021
Acurx Presents Positive Ibezapolstat Microbiome Data from Its Phase 2a Trial at IDWeek
Yahoo Finance 10/4/2021
Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2021
Yahoo Finance 9/30/2021
Acurx Pharmaceuticals to Participate in the A.G.P. Biotech and Specialty Pharma Conference October 13, 2021
Yahoo Finance 9/29/2021
Acurx Announces New Microbiome Data from Its Phase 2a Clinical Trial of Ibezapolstat for CDI in a Scientific Poster Presentation at IDWeek 2021 Conference
Yahoo Finance 9/27/2021
We Think Acurx Pharmaceuticals (NASDAQ:ACXP) Can Easily Afford To Drive Business Growth
Yahoo Finance 9/25/2021
CEO Spotlight: Acurx Pharmaceuticals in Focus with CEO David Luci Talking Potentially Transformative Phase 2b Trial, Pipeline, and Potential Near-Term Catalysts
Yahoo Finance 9/13/2021
Acurx Pharma to join the Russell Microcap Index
Seeking Alpha 9/2/2021
Acurx Pharmaceuticals to Join the Russell Microcap Index®
Yahoo Finance 9/2/2021
Top MarketXLS Rank stocks
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started today
Stand with Ukraine
As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.
For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention
From all of us at MarketXLS, thank you!